GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » EV-to-FCF

Sichuan Kelun Pharmaceutical Co (SZSE:002422) EV-to-FCF : 15.99 (As of Jun. 13, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sichuan Kelun Pharmaceutical Co's Enterprise Value is ¥50,009 Mil. Sichuan Kelun Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,128 Mil. Therefore, Sichuan Kelun Pharmaceutical Co's EV-to-FCF for today is 15.99.

The historical rank and industry rank for Sichuan Kelun Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

SZSE:002422' s EV-to-FCF Range Over the Past 10 Years
Min: -2103.3   Med: 17.71   Max: 26965.81
Current: 15.86

During the past 13 years, the highest EV-to-FCF of Sichuan Kelun Pharmaceutical Co was 26965.81. The lowest was -2103.30. And the median was 17.71.

SZSE:002422's EV-to-FCF is ranked better than
63.69% of 537 companies
in the Drug Manufacturers industry
Industry Median: 22.8 vs SZSE:002422: 15.86

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-13), Sichuan Kelun Pharmaceutical Co's stock price is ¥32.15. Sichuan Kelun Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.730. Therefore, Sichuan Kelun Pharmaceutical Co's PE Ratio for today is 18.58.


Sichuan Kelun Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co EV-to-FCF Chart

Sichuan Kelun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.38 37.46 18.35 19.68 13.36

Sichuan Kelun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.51 11.19 11.30 13.36 16.32

Competitive Comparison of Sichuan Kelun Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - General subindustry, Sichuan Kelun Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Kelun Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Kelun Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sichuan Kelun Pharmaceutical Co's EV-to-FCF falls into.



Sichuan Kelun Pharmaceutical Co EV-to-FCF Calculation

Sichuan Kelun Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=50008.656/3127.801
=15.99

Sichuan Kelun Pharmaceutical Co's current Enterprise Value is ¥50,009 Mil.
Sichuan Kelun Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,128 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Kelun Pharmaceutical Co  (SZSE:002422) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sichuan Kelun Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.15/1.730
=18.58

Sichuan Kelun Pharmaceutical Co's share price for today is ¥32.15.
Sichuan Kelun Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.730.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sichuan Kelun Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Traded in Other Exchanges
N/A
Address
No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071
Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.
Executives
Lai De Gui Executives
Feng Hao Directors, executives
Liu Si Chuan Directors, executives
Wang Jing Yi Directors, executives
Wan Yang Yu Executives
Ge Jun You Executives
Wu Zhong Hua Executives
Wan Peng Supervisors
Tan Hong Bo Executives
Liu Ge Xin Director
Huang Xin Securities Affairs Representative
Ge Tao Executives
Pan Hui Directors, executives
Zhou Xiao Dong Executives
Zheng Chang Yan Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines